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Macrophage tumour cell lines (PUS-1.8, P388Dl) produced detectable granulocyte macrophage colony- 
stimulating (CSF-2) activity measured using a factor-dependent cell line FDC-PI. The production of CSF-2 
was enhanced by endotoxin and inhibited by serum, and correlated inversely with [3H]TdR incorporation. 
mRNA isolated from PU5- 1.8 or P388D 1 cells initiated CSF-2 production when injected into Xenopus laevis 
oocytes. The specific activity in this assay was unaltered in mRNA isolated from endotoxin-treated cells. 
The results uggest that endotoxin acts at a post-transcriptional level. 
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1. INTRODUCTION 
Granulocyte-macrophagecolony-stimulatingfac- 
tor (CSF-2) is a glycoprotein hormone that 
regulates colony formation by immature 
haemopoietic stem cells [l]. In addition, CSF-2 
causes proliferation of mature macrophages [2,3]. 
Ralph et al. [4] have reported that macrophage-like 
tumour cells can be stimulated, by bacterial en- 
dotoxin, to release a granulocyte-macrophage 
colony-stimulating activity. Here, we have re- 
examined the production of CSF-2 activity by the 
macrophage-like tumour cell lines P388Dl and 
PU5-1.8 using, as an assay, the factor-dependent 
cell line FDC-Pl [5,6]. Our results suggest that 
P388Dl and PUS-l.8 are constitutive producers of 
CSF-2 and that induction by endotoxin does not 
involve an increase in CSF-2 specific mRNA. 
bovine serum, 2 mM glutamine and gentamycin 
(60 U/ml). FDC-Pl cells additionally required 
30% WEHl-3 conditioned medium as a source of 
interleukin 3 [5,6]. Endotoxin from the heptose- 
deficient mutant R595 of Salmonella minnesota (a 
gift from Professor W. Doe) was prepared, 
sonicated and dissolved in 0.1% triethylamine as in 
171. 
2.2. RNA preparation 
2. MATERIALS AND METHODS 
2.1. Culture media 
PU5-1.8 cells were maintained in Dulbecco’s 
modified Eagle’s minimal essential medium, 
WEHl-3, P388Dl and FDC-Pl cells in 
RPMl-1640. All media contained 10% foetal 
RNA was prepared from batches of lo9 
WEHl-3, PU5-1.8 or P388Dl cells that were grow- 
ing exponentially with or without 24 h pretreat- 
ment with 1 ,ug/ml endotoxin. RNA was extracted 
using guanidine isothyanate [8], and fractionated 
by centrifugation through a caesium chloride step 
gradient [9]. There was no difference in RNA yield 
from control or endotoxin-treated cells, lo9 cells 
yielding 2-4 mg RNA. Poly(A)+ RNA was 
isolated by one passage over an oligo(dT) cellulose 
column [lo]. The biological activity of the 
poly(A)+ RNA was checked in a rabbit reticulocyte 
lysate in vitro translation system [l 1] and no dif- 
ferences in specific activity per pug were found bet- 
ween preparations from endotoxin-treated and un- 
treated cells. 
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2.3. Oocyte translates Table I 
Fifty nl poly(A)+ RNA (1 mg/ml in 10 mM 
Tris-HCl, pH 7.5, 1 mM EDTA) was injected into 
each of 15-18 Xenopus laevis oocytes. The oocytes 
were incubated for 48 h at 21°C in 100~1 medium 
[ 121. Supernatants were harvested and assayed for 
FDC-Pl growth factor activity. 
Growth and production of CSF-2 by macrophage-like 
tumour cell lines 
2.4. Growth assays 
FDC-Pl cells were washed thoroughly and 
plated at 2 x lo4 cells/well in 200 ,zl RPMl-1~0 + 
10% foetal bovine serum, The test samples were 
assayed in serial l/2 dilutions starting from l/4 
final concentration. After 30 h, the cells were 
pulsed overnight (16 h) with 0.5 ,&i [3H]th~idine 
(TdR) (2 Ci/mmol; Amersham, Bucks) harvested 
automatically onto glass-fibre discs, and counted 
by liquid scintillation counting. EDSO units are 
defined as the amount of factor required to cause 
l/2 maximal stimulation of [3H]TdR incorpora- 
tion. The assay detects approx. 0.005 EDSO 
units/ml. Proliferation of P388Dl and PU5-1.8 
cells is assayed in the same way, except that the 
plates were subjected to a cycle of freeze-thawing 
to disrupt adherent cells before harvesting. 
3. RESULTS AND DISCUSSION 
FDC-Pl is a myelomonoc~ic line that requires 
either interleukin 3 (IL3) or CSF-2 for continued 
proliferation [6]. Table 1 shows a comparison of 
the rates of growth and release of FDC-Pl growth 
factor activity by P388Dl and PU5-1.8. In 
preliminary experiments, we established that 
1 ,ug/ml endotoxin does not influence the titre of 
CSF-2 or IL3 activity measured on FDC-Pl cells 
(not shown). Like Ralph et al. 141, we observed 
that bacterial endotoxin inhibits the growth of 
PU5-1.8. In this respect, the cell lines differ from 
mouse bone marrow-derived macrophages [ 131 
which are unaffected by IO-fold higher concentra- 
tions of endotoxin. P388Dl cells, which are poorly 
adherent, and proliferate faster than PUS-1.8, 
were less affected by endotoxin. Ralph et al. 141 
could not detect constitutive secretion of CSF-2 us- 
ing the conventional colony assay, However, the 
FDC-Pl assay is sufficiently sensitive to detect a 
low level of CSF-2 production even without added 
endotoxin. The concentration of serum is an im- 
portant variable, and CSF-2 elaboration is max- 
Serum i3H]TdR incorpora- FDCP-I growth 
tion (cpm) factor 
PUS-l.8 - + - + 
0 8286 7.50 0.2 2.7 
0.5 - 0.6 4.9 
1 16045 5031 0.4 4.2 
2 20316 9843 0.3 2.1 
5 23 375 13514 0.2 1.2 
10 42691 14882 - - 
20 39 365 23 269 0.1 0.5 
P388Dl - i” 1 + 
0 19391 12 193 0.1 0.3 
0.5 38731 21438 0.5 1.3 
I 55 568 35631 0.5 1.2 
2 56633 47 099 0.5 1.0 
5 52 540 38 193 0.4 1.0 
10 61734 44454 - _ 
20 65 425 42458 0.3 0.5 
FDC-Pl growth factor was assayed (section 2) in the 
supernatants of cells cultured 48 h at an initial density of 
2 x lO’/ml in 1 ml RPMl-1640 + appropriate additions 
of serum + or - endotoxin (1 pg/ml). Results are 
expressed as EDso units/ml. Results are the average of 
duplicates. [‘HlTdR incorporation was assayed as 
described in section 2 
imal at between 0.5 and 1% serum. Endotoxin 
(1 pg/ml) causes an 8-IO-fold enhancement of 
CSF-2 elaboration by PUS-l.8 cells at low serum 
concentrations. P388Dl cells, in addition to 
responding less strongly to the growth inhibitory 
effect of endotoxin, produce less CSF-2. Having 
established optimal conditions for production, we 
showed that none of the FDC-Pl growth factor ac- 
tivity in PUS-l.8 (or P388Dl) conditioned medium 
could be attributed to IL3 since no activity was 
detectable using another factor-dependent cell line, 
32D-C123, which responds to IL3 and interleukin 
2, but not CSF-2 [6] (not shown). The absence of 
IL3 mRNA from P388Dl and PUS-l.8 cells has 
been confirmed using a specific cDNA probe [12] 
(KMS, DAH, in preparation). 
We wished to ascertain whether the action of en- 
dotoxin was due to increased transcription of 
mRNA for CSF-2. To test this, we prepared 
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poly(A)+ RNA from control and endotoxin- 
stimulated PU5-1.8 and P388Dl cells. The yields 
of RNA and the specific activity in the rabbit 
reticulocyte lysate in vitro translation system were 
unaltered by the endotoxin treatment (section 2). 
Table 2 shows the results when this mRNA was in- 
jected into X. laevis oocytes and the supernatants 
assayed for CSF-2 activity. 
In 3 separate xperiments, we found no evidence 
for induction of translatable mRNA for CSF-2 by 
endotoxin. The amount of FDC-Pl growth factor 
produced by the oocytes injected with mRNA from 
P388Dl or PUS-l.8 was 30-40 times less than 
observed with WEHl-3 mRNA. This is not sur- 
prising, since, under comparable conditions, 
WEHl-3 cells produce up to 1000 times more 
FDC-Pl growth factor activity than endotoxin- 
stimulated PUS-l.8 cells being constitutive high- 
level secretors of IL3 [12]. The enhanced expres- 
sion of IL3 mRNA in WEHl-3 cells permitted the 
recent cloning of this factor using the oocyte 
translate/FDC-Pl cell assay system [12]. 
The results suggest hat macrophage-like tumour 
cell lines are constitutive producers of a growth 
factor (CSF-2) to which normal macrophages can 
respond [3]. This provides a possible explanation 
for their autonomous growth which contrasts with 
the factor-dependence of normal macrophages 
[2,13,14]. There are several other growth factors 
implicated in autocrine stimulation of growth, 
e.g., platelet-derived growth factor [15] and in- 
Table 2 
Translation of CSF-2 messenger RNA in X. laevis 
oocytes 





PUS-l.8 (endotoxin-treated) 0.22 
P388Dl 0.20 
P388Dl (endotoxin-treated) 0.21 
Blank (buffer-injected) 0.005 
The experiment was carried out as described in section 2. 
The limit of detection is 0.005 EDSO units/ml. The results 
are representative of 3 determinations using separate 
preparations of RNA and oocytes 
terleukin 2 [16], and tumourogenesis can result 
from transmission of an oncogene encoding an 
analogue of such a growth factor (see [15]). It will 
be interesting to see whether the recently published 
cDNA sequence for CSF-2 [17] resembles any 
oncogene. 
Definite analysis of the mechanism of action of 
endotoxin on CSF-2 production will await the 
availability of specific assays for the receptor. 
However, we consider the most likely explanation 
to be an interference with the action of endogenous 
CSF-2, so that the factor no longer interacts with 
receptors on the producing cell, but is released into 
the medium. In support of this proposal, endotox- 
in has been shown to cause down regulation of 
CSF-1 receptors on mouse macrophages [ 181. Fur- 
ther studies will be directed towards understanding 
interaction between endotoxin and receptors for 
CSF-2 on proliferating macrophages. 
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